Pharmafile Logo
Pharmafocus logo
Advanced Search

RSA makes three new appointments

December 22, 2011
Business Services, Medical Communications, Sales and Marketing rsa

Life sciences recruitment firm RSA has announced three new appointments to its UK office. Dr David Jay joins RSA UK …

Appointment

FDA accepts Pfizer’s arthritis pill for review

December 22, 2011
Research and Development, Sales and Marketing FDA, Pfizer, tofacitinib

The FDA has accepted Pfizer’s novel arthritis pill tofacitinib for review, and could be on the US market next year. …

News
GSK picture

GSK sells off over-the-counter brands

December 22, 2011
Sales and Marketing GSK, OTC

GlaxoSmithKline has offloaded a number of OTC consumer health brands in North America for £426 million in cash.  Flagged up …

News

Department of Health slims down agency partners

December 21, 2011
Medical Communications DH, Freud Communications, MEC

The Department of Health has stripped back its use of comms agencies in its public health campaigns by switching to …

News

AstraZeneca takes option on new diabetes candidates

December 21, 2011
Sales and Marketing AstraZeneca, diabetes

AstraZeneca and Prosidion, a subsidiary of Astellas have signed a deal giving AstraZeneca an exclusive option to acquire two diabetes …

News
andy_bowmanweb

Caudex Medical makes two senior appointments

December 21, 2011
Business Services, Medical Communications, Sales and Marketing Andy Bowman, Caudex Medical, Gary Burd

Andy Bowman and Gary Burd have been appointed to senior positions within the medical communications firm Caudex Medical.  Bowman has …

Appointment
FDA picture

FDA to probe Gilenya patient death

December 21, 2011
Sales and Marketing FDA, Novartis, gilenya

The FDA is investigating Novartis’s new multiple sclerosis treatment Gilenya after a patient died within hours of taking the drug. …

News

Lilly teams up with ImmunoGen on antibody-drug conjugates

December 21, 2011
ADC, Cancer, Immunogen, T-DM1, conjugate, lilly, oncology

ImmunoGen has signed a new collaboration with Eli Lilly to develop antibody-drug conjugate for cancer treatments.Lilly will pay an upfront …

News

Xarelto gains new licences in UK

December 20, 2011
Sales and Marketing

Bayer’s anticoagulant pill Xarelto has gained two new lucrative licences, and is now available in the UK to prevent stroke …

News

AstraZeneca, Novo and Enlight sign collaborative research deal

December 20, 2011
Research and Development, Sales and Marketing AstraZeneca, Enlight, Novo Nordisk

AstraZeneca and Novo Nordisk have linked up with a US biosciences firm in a bid to enhance their R&D operations. …

News

Pharma manufacturing news in brief

December 20, 2011
Manufacturing and Production ADC Biotechnology, BioMarin, GE Healthcare, Lonza and Neptune Technologies, M+W Group

Facility news from BioMarin, Lonza and Neptune Technologies, plus plans to boost biomanufacturing capacity in the developing world and new …

News

Akzo Nobel warned by FDA over Mexican facility

December 20, 2011
Manufacturing and Production Akza Nobel, manufacturing

Akzo Nobel has been taken to task by the US FDA for manufacturing standards at one of its active pharmaceutical …

News

AstraZeneca posts drug failures, takes $382m hit

December 20, 2011
Research and Development, Sales and Marketing AstraZeneca, depression, ovarian cancer

AstraZeneca has taken a major blow to its late stage pipeline, with one of its key cancer drugs now being …

News
Brilique picture

Brilique recommended for use by Germany’s pricing watchdog

December 19, 2011
Sales and Marketing AstraZeneca, Brilique, Plavix

Germany’s new pricing committee has said that AstraZeneca’s Brilique is a cost effective treatment for patients with a certain heart …

News

Ex-EMA chief ran consultancy firm whilst still in office

December 19, 2011
Sales and Marketing EMA, Lonngren, NDA

The former head of the European Medicines Agency Thomas Lonngren set up his own consultancy business to advise pharma whilst …

News
Gilenya picture

Key product launches of 2011

December 19, 2011
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing 2011, Actos, Benlysta, Brilique, Eliquis, Eylea, Incivek, Jevtana, Multaq, Victrelis, Xalkori, Yervoy, Zytiga, avastin, gilenya, key products

 Avastin 2011 saw a handful of high profile drugs suffer because of new safety and efficacy concerns. Chief among these …

Feature

Vertex chief to step down; names Jeffrey Leiden as new leader

December 19, 2011
Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Abbott, Vertex

Vertex has named a new chief executive to succeed Matthew Emmens, who will retire early next year. He will be …

Appointment

Priorclave Success at London Vet show

December 19, 2011
Manufacturing and Production

During the recent London Vet Show the autoclave featured on the Southwest Medical stand R30 certainly proved a popular visitor …

News
Press release

University Teaching Labs Buy into Priorclaves for Better Performance

December 19, 2011
Manufacturing and Production

York University is shortly taking delivery of a number of priorclaves for use in the Biology Department’s Teaching Laboratories and …

News
Press release
Sanofi picture

Sanofi sheds dermatology unit for $423 million

December 19, 2011
Manufacturing and Production, Sales and Marketing Canada, Dermik, Sanofi

Sanofi has completed the sale of its Canadian-based dermatology business Dermik for $422.5 million.  The unit has been sold to …

News
The Gateway to Local Adoption Series

Latest content

Rentschler Biopharma appoints Uwe Buecheler as interim CEO

January 26, 2026

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026

PSI appoints David Allen as Country Manager for Canada

January 22, 2026

Qureight appoints Steven Bishop as Chief Medical Officer

January 21, 2026

Pierre Fabre Laboratories and Iktos announce oncology collaboration

January 21, 2026